Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease

Neuroscience Letters

Volumn 260, Issue 2, 1999, Pages 77-80

  Marie R M ^a,b   Barre L ^c   Dupuy, B ^d   Viader, F ^b   Defer, G ^b   Baron, J C ^a  

^a INSERM   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c Cyceron   (France)

^d CH L Pasteur   (France)

Author keywords

11C S nomifensine; Basal ganglia; Frontal functions; Nomifensine; Positron emission tomography; Striato frontal circuits; Working memory

Indexed keywords

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; DOPAMINERGIC SYSTEM; FEMALE; FRONTAL CORTEX; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE FIBER TRANSECTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STATE DEPENDENT LEARNING; STRIATE CORTEX; TASK PERFORMANCE; WORKING MEMORY;

ADULT; AGED; CAUDATE NUCLEUS; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOMIFENSINE; PARKINSON DISEASE; SYMPATHECTOMY, CHEMICAL; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033613715     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00928-8     Document Type: Article

References (26)

1. Alexander G.E., Crutcher M.D., DeLong M.R. Basal ganglia thalamo-cortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog. Brain Res. 85:1990;119-146.
2. Brooks D.J., Salmon E.P., Mathias C.J., Quinn N., Leenders K.L., Bannister R., Marsden C.D., Frackowiak R.S.J. The relationship between locomotor disability, autonomic dysfunction and the integrity of the striatal dopaminergic system in patients with multiple-system atrophy, pure autonomic failure and parkinson's disease, studied with PET. Brain. 113:1990;1539-1552.
3. Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., Sullivan E.V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain. 114:1991;2095-2122.
4. Freedman M. Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease. Brain Cognit. 14:1990;134-143.
5. Freedman M. Orbitofrontal function, object alternation and perseveration. Cereb. Cortex. 8:1998;18-27.
6. Fuster, J.M., The Prefrontal Cortex. Anatomy, Physiology and Neuropsychology of the Frontal Lobe, 3rd edn., Raven, New York, 1997.
7. Gaspar P., Duyckaerts C., Alvarez C., Javoy-Agid F., Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann. Neurol. 30:1991;365-374.
8. Goldman-Rakic, P.S., Cellular and circuit basis of working memory in prefrontal cortex of nonhuman primates. In Uyling, H.B.M., Van Eden, C.G., De Bruin, J.P.C., Corner, M.A. and Feenstra, M.G.P. (Eds.), Progress in Brain Research, Vol. 6, 1990, pp. 325-336.
9. Gotham A.M., Brown R.G., Marsden C.D. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain. 111:1988;299-321.
10. Holthoff V.A., Vieregge P., Kessler J., Pietryck U., Herholz K., Bonner J., Wagner R., Wienhard K., Pawlik G., Heiss W.D. Discordant twins with Parkinson's disease: Positron Emission Tomography and early signs of impaired cognitive circuits. Ann. Neurol. 36:1994;176-182.
11. Holthoff-Detto V.A., Kessler J., Herholz K., Bonner H., Pietzyk U., Wurker M., Ghaemi M., Wienhard K., Wagner R., Heiss W.D. Functional effects of striatal dysfunction in Parkinson Disease. Arch. Neurol. 54:1997;145-150.
12. Lange K.W., Paul G.M., Robbins T.W., Marsden C.D. L-DOPA and frontal cognitive function in Parkinson's disease. Adv. Neurol. 60:1993;475-478.
13. Leenders K.L., Salmon E.P., Tyrrell P., Perani D., Brooks D.J., Sager H., Jones T., Marsden D., Frackowiak R.S.J. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteers subjects and patients with parkinson's disease. Arch. Neurol. 47:1990;1290-1298.
14. Lezak, M.D., Neuropsychological Assessment, 2 edn., Oxford University Press, New York, 1983.
15. Marié R.M., Barré L., Allain P., Rioux P., Lechevalier B., Baron J.C. PET imaging of neocortical monoaminergic terminals in Parkinson's disease. J. Neural Trans. (PD-section). 9:1995;55-71.
16. Marié R.M., Rioux P., Eustache F., Travère J.M., Lechevalier B., Baron J.C. Clues about the functional neuroanatomy of working memory in Parkinson's disease. Eur. J. Neurol. 2:1995;83-94.
17. Morris R.G. Short-term forgetting in senile dementia of the Alzheimer's type. Cognit. Neuropsychol. 3:1986;77-97.
18. Owen A.M., James M., Leigh P.N., Summers B.A., Marsden C.D., Quinn N.P., Lange K.W., Robbins T.W. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain. 115:1992;1727-1751.
19. Owen A.M., Doyon J., Dagher A., Sadikot A., Evans A.C. Abnormal basal ganglia outflow in Parkinson's disease identified with PET: implications for higher cortical functions. Brain. 121:1998;949-965.
20. Petrides M. Deficit in non spatial conditional associative learning after periarcuate lesions in the monkey. Behav. Brain Res. 16:1985;95-101.
21. Petrides M. Nonspatial conditional learning impaired in patients with unilateral frontal but not unilateral temporal lobe excisions. Neuropsychologia. 28:1990;137-149.
22. Roberts A.C., De Salvia M.A., Wilkinson L.S., Collins P., Everitt B.J., Robbins T.W. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analogue of the Wisconsin card sort test: possible interactions with subcortical dopamine. J. Neurosci. 14:1994;2531-2544.
23. 11C]nomifensine uptake using positron emission tomography. J. Cereb. Blood Flow Metab. 10:1990;307-316.
24. Scatton B., Dubois A., Dubocovich M.L., Zahniser N.R., Fage D. Autoradiographic visualization and quantification of dopamine receptors and uptake sites in the rat and human CNS. Life Sci. 36:1985;815-822.
25. Schacht U., Leven M. Stereoselective inhibition of synaptosomal catecholamine uptake by nomifensine. Eur. J. Pharmacol. 98:1984;275-277.
26. White N.M. Mnemonic functions of the basal ganglia. Curr. Opin. Neurobiol. 7:1997;164-169.